1. Sponsor acknowledgements
Title of Abstract Goes Here – Please Make Sure Study Number is Listed in Title
Author’s Names
Author’s Affiliations
Disclosures: Sample text sample text sample text
ABSTRACT
OBJECTIVES
RESULTS
Bullet Number One – sample text sample text sample text sample text sample sample text sample text sample text sample text sample text sample text sample text sample text sample text sample text sample text.
Bullet Number Two – sample text sample text sample text sample text sample sample text sample text sample text sample text sample text sample text sample text sample text sample text sample text sample text.
Poster development instructions:
Be sure to check the poster specifications for each meeting as these often vary from meeting to meeting. You should know the poster size prior to starting to layout your poster.
The components included in this template are not necessarily required (such as “Abstract”) and those not required can be deleted.
PATIENTS
Bullet Number One – sample text.
Bullet Number Two – sample text sample text.
Table IV. Patient Accrual
sample text sample text sample text
Table VII. Overall
sample text sample text sample text 100
Table I. Patient Accrual
sample text sample text sample text 100
ELIGIBILITY
Bullet Number One – sample text sample text sample text sample text sample sample text sample text sample text sample text sample text sample text sample text sample text sample text sample text sample text.
Bullet Number Two – sample text sample text sample text sample text sample sample text sample text sample text sample text sample text sample text sample text sample text sample text sample text sample text.
Bullet Number Three – sample text sample text sample text sample text sample sample text sample text sample text sample text sample text sample text sample text sample text sample text sample text sample text
Table VIII. Causes of Death
sample text sample text sample text 100
Background: Be sure to check the poster specifications for each meeting as these often vary from meeting to meeting. You should know the poster size prior to starting to layout your poster. The components included in this template are not necessarily required and those not required can be deleted. Again, poster specification can typically be found on the meeting organizers Web site.
Methods: Patients with tumors Patients with tumors Patients with tumors Patients with tumors Patients with tumors Patients with tumors Patients with tumors Patients with tumors Patients with tumors Patients with tumors.
Results: 106 patients were enrolled 106 patients were enrolled 106 patients were enrolled 106 patients were enrolled 106 patients were enrolled 106 patients were enrolled 106 patients were enrolled 106 patients were enrolled 106 patients were enrolled 106 patients were enrolled 106 patients were enrolled 106 patients were enrolled 106 patients were enrolled 106 patients were enrolled 106 patients were enrolled 106 patients were enrolled
Conclusion: Both regimens were well tolerated with acceptable Both regimens were well tolerated with acceptable Both regimens were well tolerated with acceptable tolerated with acceptable Both regimens were well tolerated with acceptable Both regimens were well tolerated with acceptable Both regimens were well tolerated with acceptable
SAFETY AND TOXICITY
Table V. Pretreatment
sample text sample text sample text
Sample text sample text sample text
Table II. Pretreatment
sample text sample text sample text 100
CONCLUSIONS
Sample text Sample text Sample text Sample text Sample text Sample text Sample text Sample text Sample text Sample text
Sample text Sample text Sample text Sample text Sample text
STUDY DESIGN
EFFICACY
Figure 1: Treatment Schema.
BACKGROUND
REFERENCES
Sample text sample text sample text sample text sample text sample text sample text sample text sample text sample text.
Sample text sample text sample text sample text sample text sample text sample text sample text sample text sample text
Table III. Pathologic Response
sample text sample text sample text 100
Aim 1
Number One – sample text sample text sample text sample text sample sample text sample text
Number Two – sample text sample text sample text sample text sample sample text sample text.
Aim 2
Bullet Number One – sample text sample text sample text sample text sample sample text sample text sample text sample text sample text sample text sample text sample text sample text sample text sample text sample text sample text sample text sample text sample text sample text sample text text sample text.
Bullet Number Two – sample text sample text sample text sample text sample sample text sample text sample text sample text sample text sample text sample text sample text sample text sample text sample text sample text sample text sample text sample text sample text sample text sample text text sample text.
Table VI. Toxicities
sample text sample text sample text 100
Sponsor acknowledgements
NCT number